M Rudert1, B M Holzapfel, E von Rottkay, D E Holzapfel, U Noeth. 1. Department of Orthopaedic Surgery, University of Wuerzburg, Koenig-Ludwig-Haus, Brettreichstr. 11, 97072, Wuerzburg, Germany, m-rudert.klh@uni-wuerzburg.de.
Abstract
OBJECTIVE: Regeneration of autologous bone stock and formation of a stable implant bed by impaction of morselized bone allograft. INDICATIONS: Bone loss after septic and aseptic loosening or tumour resection. CONTRAINDICATIONS: Persistent infection, one-stage septic revision, poor therapeutic compliance, extensive uncontained metaphyseal defects with cortical thinning of the diaphysis. SURGICAL TECHNIQUE: Whilst the surgeon removes the loose prosthesis, the assistant prepares the graft. The medullary canal is sealed with a cement restrictor. Graft particles of different sizes are densely impacted around a trial stem. The highest level of stability is achieved by using large particles interspersed with small filler particles. Low-viscosity cement facilitates cement penetration and ensures strong interdigitation with the impacted graft mass after implantation of the prosthesis. Uncontained metaphyseal defects are treated with prosthetic augments. POSTOPERATIVE MANAGEMENT: Gait training, physiotherapy with isometric quadriceps exercises, partial weight-bearing for 6 weeks, resistance training begins 8 weeks postoperatively. RESULTS: Between 2010 and 2012, 28 patients with large bone defects [Anderson Orthopaedic Research Institute (AORI) grade: 21 × F3, 3 × F2, 13 × T3, 8 × T2] underwent total knee revision with impaction bone grafting. The mean follow-up was 27.7 months (range 21-47 months). On average, patients had undergone 2.5 previous revisions. Implant survival was 82.0 % (95 % CI = 62.5 %-92.1 %) for any reason of revision as the endpoint and 93.1 % (95 % CI = 74.5-98.4 %) for aseptic revision as the endpoint. The mean postoperative Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score was 35.4 (range 3.3-101.6, SD ± 26.2). The mean KSS was 70.6 (range 20-100, SD ± 26.8).
OBJECTIVE: Regeneration of autologous bone stock and formation of a stable implant bed by impaction of morselized bone allograft. INDICATIONS: Bone loss after septic and aseptic loosening or tumour resection. CONTRAINDICATIONS: Persistent infection, one-stage septic revision, poor therapeutic compliance, extensive uncontained metaphyseal defects with cortical thinning of the diaphysis. SURGICAL TECHNIQUE: Whilst the surgeon removes the loose prosthesis, the assistant prepares the graft. The medullary canal is sealed with a cement restrictor. Graft particles of different sizes are densely impacted around a trial stem. The highest level of stability is achieved by using large particles interspersed with small filler particles. Low-viscosity cement facilitates cement penetration and ensures strong interdigitation with the impacted graft mass after implantation of the prosthesis. Uncontained metaphyseal defects are treated with prosthetic augments. POSTOPERATIVE MANAGEMENT: Gait training, physiotherapy with isometric quadriceps exercises, partial weight-bearing for 6 weeks, resistance training begins 8 weeks postoperatively. RESULTS: Between 2010 and 2012, 28 patients with large bone defects [Anderson Orthopaedic Research Institute (AORI) grade: 21 × F3, 3 × F2, 13 × T3, 8 × T2] underwent total knee revision with impaction bone grafting. The mean follow-up was 27.7 months (range 21-47 months). On average, patients had undergone 2.5 previous revisions. Implant survival was 82.0 % (95 % CI = 62.5 %-92.1 %) for any reason of revision as the endpoint and 93.1 % (95 % CI = 74.5-98.4 %) for aseptic revision as the endpoint. The mean postoperative Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score was 35.4 (range 3.3-101.6, SD ± 26.2). The mean KSS was 70.6 (range 20-100, SD ± 26.8).
Authors: Douglas G Dunlop; Nigel T Brewster; S P Gopal Madabhushi; Asif S Usmani; P Pankaj; Colin R Howie Journal: J Bone Joint Surg Am Date: 2003-04 Impact factor: 5.284
Authors: Sanne van der Donk; Tim Weernink; Pieter Buma; Per Aspenberg; Tom J J H Slooff; B Willem Schreurs Journal: Clin Orthop Relat Res Date: 2003-03 Impact factor: 4.176
Authors: Colin A McNamara; Raúl G Gösthe; Preetesh D Patel; Kristopher C Sanders; Gustavo Huaman; Juan C Suarez Journal: Arthroplast Today Date: 2016-11-03
Authors: Yunong Ao; Lin Guo; Hao Chen; Rui He; Pengfei Yang; Dejie Fu; Lingchuan Gu; Yang Peng; Ran Xiong; Liu Yang; Fuyou Wang Journal: Front Bioeng Biotechnol Date: 2022-09-05
Authors: C Fölsch; P Sahm; C A Fonseca Ulloa; G A Krombach; M Kampschulte; M Rickert; A Pruss; A Jahnke Journal: Cell Tissue Bank Date: 2021-04-24 Impact factor: 1.522